RAC 2.20% $1.78 race oncology ltd

[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene, page-82

  1. 469 Posts.
    lightbulb Created with Sketch. 70
    BlueGMs, what type of level of attention do you think the FDA should be demonstrating given the recent investor update and other mediums.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.